Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

AIE regimen

A regimen consisting of cytarabine (Ara-C), idarubicin and etoposide, used as an induction treatment for pediatric acute myeloid leukemia (AML). High-dose cytarabine/etoposide/idarubicin regimen may be used for the treatment of AML.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:AraC-idarubicin-etoposide regimen
cytarabine-idarubicin-etoposide regimen
MRC AML10 study-AIE regimen
Abbreviation:AIE
ICE
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search